LONDON (Alliance News) - Hikma Pharmaceuticals PLC Wednesday said it has priced a USD500 million 4.25% eurobond due April 2020, with the proceeds to be used to refinance existing debt and for "general" corporate purposes.
The bond will be listed on the Global Exchange Market of the Irish Stock Exchange.
The joint lead managers were Citi, Barclays, HSBC and National Bank of Abu Dhabi.
Hikma shares closed up 0.1% at 2,131.00 pence in London on Wednesday.
Copyright 2015 Alliance News Limited. All Rights Reserved., source Alliance News